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DISCUSSION
Dr Kimberley Hansen (Winston-Salem, NC). The questions
I have are two. The first involves simultaneous treatment of asymp-
tomatic visceral vascular disease. We have not treated asymptom-
atic disease unless the visceral lesion was in the same area of
exposure for the renal artery reconstruction, say, a hypoplasia that
involved both the visceral artery origins and the renal artery ori-
gins. In those instances, when you haven’t repaired the visceral
arteries, how many kids have returned with either acute or chronic
visceral syndrome?
The second question has to do with the use of nephrectomy.
The real challenge in these patients is that these repairs have to
work for 50, 60, 70 years. How do you balance the value of
nephrectomy versus disease untreated as regards to renal function?
That is, when would you consider leaving renovascular disease
unrepaired, either primary or recurrent, versus nephrectomy and
loss of renal function?
Dr James C. Stanley.The only time we believe it is reasonable
to reconstruct the celiac or superior mesenteric arteries is when
undertaking a patch aortoplasty or renal artery reconstruction in
immediate juxtaposition to these splanchnic vessels. That was the
case in 15 of our patients. Otherwise, to reconstruct these arteries
if distant from the aortorenal reconstruction may not be appropri-
ate. However, two of the nine patients initially untreated for their
splanchnic artery narrowings developed later intestinal angina with
postprandial abdominal pain and a failure to grow. They both
underwent late splanchnic arterial reconstruction.
Dr Hanson and his group have published much on renal
function related to pediatric renovascular hypertension. We en-
countered only one patient with intractable preoperative renal
failure. This was a 3-month-old infant with diastolic dysfunction,
a creatinine of 1.1, and recurrent flash-pulmonary edema. Other
patients had significant renal insufficiency, with creatinines of
0.7 or 0.8, when they’re 3 or 4 years old, which is clearly out of
the norm for that age group, considering their gender and the
muscle mass and all. In these patients it would be hazardous to
undertake a nephrectomy. Nevertheless, a number of our nephrec-
tomies were performed for kidneys 1.5 to 2.0 cm in size that
contributed little to overall renal function.
Although the original nephrectomy rate in this series was low,
the secondary nephrectomy rate was higher, perhaps because we
initially tried to reconstruct some irreparably diseased renal arter-
ies. Certainly, it is reasonable to defer renal artery reconstruction if
such carries a high risk for failure. We have not encountered that
scenario, but the prohibitively small size of renal arteries in a
newborn might be, and delaying operative therapy in this setting is
not unreasonable.
Dr Louis Messina (San Francisco, Calif). Dr Stanley, I com-
pliment you on a really remarkable and unique series. The 0%
mortality and zero incidence of postoperative renal failure is some-
thing to which we all aspire in everything we do in vascular surgery.
You have set a very high standard. In addition, you’ve introduced
new techniques, and particularly the reimplantation of the renal
artery as the favored technique at Michigan. You mentioned that
30 of the 40 most recent patients had midrenal artery lesions.
Could you share with us what you did in order to be able to
reimplant those arteries without tension? In other words, did you
mobilize the kidneys? How did you secure them? A second ques-
tion is what type of follow-up are you currently employing in those
patients? Do you have an idea of what the relative incidence of
recurrent stenosis is?
Dr Stanley. The University of Michigan experience includes
mostly patients having ostial developmental lesions, and only 15
midrenal artery stenoses. The latter were treated most often with
an aortorenal bypass using an internal iliac artery graft. Manage-
ment of proximal ostial lesions included incision of Gerota’s fascia
about the lateral kidney allowing it to be mobilized medially so as
to reimplant the renal artery beyond the stenosis without tension.
Absorbable sutures were frequently placed through the perinephric
fascia to anchor the kidney to the retroperitoneal structures.
Follow-up included early postoperative imaging before dis-
charge, usually with conventional arteriography. Later follow-up
included careful blood pressure monitoring, ultrasonography, and
arteriography if recurrent hypertensin occurred. Among this expe-
rience, 78 patients required only one operation, with the initial
procedure being successful. However, 19 required reoperation,
and in most all, excepting our early experience with aneurysmal
vein grafts, the issues requiring a secondary procedure were evident
with predischarge imaging. Late anastomotic narrowings were
uncommon, affecting nine of the 132 kidney revascularization
procedures.
Dr Peter Gloviczki (Rochester, Minn). I have a couple of
technical questions.
How do you make a decision of a long abdominal or thoraco-
abdominal patch versus a bypass? I noticed you used PTFE, when,
especially in small children, if you would use a crimped Dacron
graft that would maybe allow more for longitudinal growth.
Then one final question. Would endovascular treatment in
some children be useful in spite of the elevated risk of recurrent
stenosis in a few years? It could delay open reconstructive surgery
in children and allow us to operate on larger blood vessels of teens
or young adults.
Dr Stanley. The real issue regarding treatment of coexisting
aortic disease is whether to do a patch aortoplasty or a thoracoab-
dominal bypass. If an aortic and renal reconstruction is to be done
just once, then a patch aortoplasty is preferred. However, because
of small aortic size or if one anticipates reoperation later, than a
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thoracoabdominal bypass may be the favored initial therapy. We’ve
had six patients whose kidneys have grown, but their renal artery
has not, and a second primary operation was required to revascu-
larize the contralateral kidney. Initial patch aortoplasty in such
patients make reoperations difficult.
Knitted or woven Dacron grafts are not favored for thoraco-
abdominal bypasses in children. Such grafts are much more subject
to late degenerative changes than extruded Teflon grafts. Interest-
ingly, a child 9 or 10 years old has completed almost all growth
from the xiphoid to the pubis. Linear growth after that age occurs
in the long bones of the lower extremities. Thus, concern about
longitudinal growth in older children is irrelevant.
Our longest follow-up of a thoracoabdominal bypass is now
42 years in a patient that mymentor, William J. Fry, operated upon
and whom I am now following. His bypass, performed when he
was a young child, is functioning perfectly fine today.
Endovascular interventions for pediatric renovascular hyper-
tension have limited application. Some have suggested that PTA
for neurofibromatosis-related ostial stenoses is a preferred therapy,
but most reports on this subject are anecdotal.
Renal artery stenoses due to an aortoarteritis like Takayasu
disease or its variants are more likely to be initially treated success-
fully by PTA, although a 15% to 30% recurrence rate in these
patients has been reported. Nevertheless, as a temporizing mea-
sure, there may be patients better served with an initial catheter-
based intervention. However, the long-term durability of this type
of therapy in these 2- and 3-mm arteries, is limited, and a failed
PTA may result in irreparable kidney damage.
Dr Richard Cambria (Boston, Mass). So in the 30 years that
I’ve been listening to you talk about renovascular disease, I’ve
learned a lot. And I’ve only done a handful of these operations. But
my question is an extension of Peter Gloviczki’s about temporizing
and timing with (A) angioplasty, and I think you just answered that
question, but (B) medical therapy. Because, obviously, over the
40 years of your experience, for a long part of that experience there
were simply not available medical therapies that could temporize
and control blood pressure in some of these younger and smaller
patients. So where does that fit in terms of your timing about age
and size of patients? Because I’m following a couple of these 3- and
4-year-olds now and, I must confess, I don’t know the answer to
the question, and perhapsmy temporizing is that I’m just too timid
to operate on them now.
Dr Stanley. Two of my coauthors are phenomenal pediatric
nephrologists who take care of these children. It is logical to
attempt to control blood pressure medically in these patients as
infants. However, after infancy, old single renal artery disease can
be treated safely, without putting the kidney or child at risk. Thus,
around age 3, if the renal artery disease is not complex, then an
experienced surgeon may proceed with an operative intervention.
From my perspective, awaiting growth of the renal artery from age
3 year to 12 years does not offer any appreciable technical benefit in
the reconstructive procedure.
Dr Ronald Stoney (Hillsborough, Calif). I have two ques-
tions. The first concerns the dilemma that we’ve often had in
staging versus choosing a single operative repair of bilateral exten-
sive disease. And the second concerns cure rate. If I read your slide
correctly, your cure rate was higher in the first two decades of your
experience and lower in the last two decades. I wonder if you have
an explanation for this?
Dr Stanley. Bilateral reconstructions are intense procedures,
not 2-hour operations, but it’s more logical to operate once and do
it right the first time. Reoperations for contralateral disease may
entail considerable technical difficulties.
The cure rate regarding hypertension was lower in recent
decades. The first two decades of this series were dominated by
single renal artery lesions without involvement of the other kid-
ney’s vessels. The more recent experience included many complex
patients that had evolving disease on the contralateral side, includ-
ing 15% of our last 40 patients who were failures of PTA performed
elsewhere. Recent outcomes most likely reflect a greater complex-
ity of the disease and a number of failed PTAs.
Dr Eleanor Iadgarova (Brooklyn, NY). I would like to know
any situations of restenosis of the renal artery and how did you treat
them?
Dr Stanley. PTA was undertaken successfully once for a distal
anastomotic stenosis. However, restenosis treated by PTA may
require stenting, and placing a stent in a 4- or a 5-year-old child is
just asking for later problems, because the vessels are going to grow
and the stent will not. Unless a local angioplastic procedure can be
performed, our experience favors an aortorenal bypass with an
internal iliac artery graft as a secondary operation in the face of a
restenosis. These reconstructions are challenging in that the bypass
must often go to the distal renal artery beyond where the initial
stenotic lesion was treated.
Dr Iadgarova. What is your follow-up protocol?
Dr Stanley. All of our patients have undergone early postop-
erative arteriography before being discharged. Occasionally in a
young child we will obtain an MRA or an intravenous digital
subtraction arteriogram with contrast administered through a
catheter in the right atrium. Patients with complex reconstructions
have repeat imaging at a year. Most other children are simply
followed with their blood pressures and ultrasound to assess kidney
size and document renal artery flow.
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